Insurance Coverage at Risk? What to do immediately.
While no one wants to think about losing their job, it is better to be prepared. This is especially true…
Special Diabetes Program Funding Extended Allowing Critical Type 1 Diabetes Research to Continue
The Federal Government has continued its commitment to support diabetes research by providing more than $75 million into the Special Diabetes Program (SDP), which…
Talking to Eli Lilly about Our Insulin Supply
Will we be OK? Our colleagues at Beyond Type One interviewed an insulin-supply expert at the Eli Lilly and Company…
Breakthrough T1D Receives Legacy Gift from the Estate of Marguerite Rosner
Generous donation furthers Breakthrough T1D mission to treat, prevent and find cures for type 1 diabetes.
New Breakthrough T1D-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion
Cost for each diagnosed American is nearly $500,000.
Insulin Affordability Matters: Advocating to Make Insulin More Affordable for All
More than 1.25 million Americans live with type 1 diabetes (T1D), and this number continues to grow. They need insulin…
FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia
On Tuesday, the type 1 diabetes (T1D) community got a helping hand in their ability to avoid severe hypoglycemia when…
Children’s Congress Photo Gallery
“It is a life dream of mine to not have ‘what is my sugar’ as my waking thought, delve into…
Children’s Congress shaped perspectives of type 1 diabetes and the need to do more
Our Breakthrough T1D Children’s Congress Delegates have left Washington, DC. But they’ve made a lasting impression and paved a solid…
FDA Welcomes Teen Perspective During Children’s Congress
What would intimidate even the most seasoned speakers had little impact on the three teens who met with the Food…
